Her2-Neu overexpression does not increase the risk of local-regional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiation

✍ Scribed by T.A Buchholz; E Huang; D Berry; E.A Strom; M.D McNeese; L Pusztai; H Kuerer; A.U Buzdar; G.N Hortobagyi; V Valero; G.H Perkins; A Sahin

• Book ID: 108435282
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 19 KB
• Volume: 57
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/s0360-3016(03)01004-6